DeutschNewstral
Article
newatlas.com on 2021-11-15 03:52
India’s Covaxin COVID-19 vaccine 77.8% effective, Lancet study finds
Related news
India’s Bharat Biotech says its Covaxin coronavirus vaccine is 81 per cent effectiveSouth China Morning Post
Coronavirus | Russia’s Sputnik V vaccine 91.6% effective: Lancet studyThe Hindu
Russia's Sputnik V vaccine 91.6% effective - Lancet studytimesofmalta.com
WHO gives green light to India’s Covaxin COVID-19 vaccineSydney Morning Herald- Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet studyThe Hindu
Russian Covid-19 Vaccine Was Highly Effective in Trial, Study Findswsj.com
Explained: What is Covaxin, India’s Covid-19 vaccine candidate; how long before approval?herald.co.zw- CResults of India’s Covaxin vaccine by 15 August: fact checks , phase 1 completedcychron.com
Covaxin phase 3 data shows 77.8% efficacy: LancetThe Times of India
Vaccine Covaxin gets OK of WHOArkansas Online
Novavax: COVID-19 vaccine about 90% effective, study findsDenver Post
India’s Leaders Perpetuated False Optimism, Unrealistic Claims About Pandemic, Lancet Editorial Saystntribune.com- Coronavirus | Russia vaccine passes early trial test: Lancet reportThe Hindu
- Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacyThe Hindu
- Vaccine: Covaxin trials done on 375 peopleThe Times of India
Covaxin: The best vaccine you can’t getamericanbazaaronline.com- Covaxin effective against Delta Plus variant: ICMRThe Times of India
Single Shot Of Pfizer-BioNTech Covid-19 Vaccine Is 85% Effective, Study FindsForbes- Mixing Covaxin and Covishield is safe and effective: ICMRThe Times of India